Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed an NS5A- or NS3-containing regimen: the ANRS HC34 REVENGE Study - de Lédinghen, V; Laforest, C; Hézode, C (Clin Infect Dis, 2018)
, et al.